{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:07:58Z","timestamp":1791972478694,"version":"4.3.4"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:00:00Z","timestamp":1725840000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.biopha.2024.117436","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T09:36:03Z","timestamp":1726133763000},"page":"117436","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Tumor-infiltrating B cells: Their dual mechanistic roles in the tumor microenvironment"],"prefix":"10.1016","volume":"179","author":[{"given":"Demin","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaozhen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runchen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huidan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.biopha.2024.117436_bib1","doi-asserted-by":"crossref","first-page":"5534","DOI":"10.1002\/cam4.1697","article-title":"Clinical landscape of cancer metastases","volume":"7","author":"Riihim\u00e4ki","year":"2018","journal-title":"Cancer Med."},{"issue":"9","key":"10.1016\/j.biopha.2024.117436_bib2","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1038\/s41388-019-1110-1","article-title":"Invasion and metastasis: the elusive hallmark of cancer","volume":"39","author":"Meirson","year":"2020","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.biopha.2024.117436_bib3","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA: a Cancer J. Clin."},{"issue":"9","key":"10.1016\/j.biopha.2024.117436_bib4","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrc.2016.73","article-title":"The biology and function of fibroblasts in cancer","volume":"16","author":"Kalluri","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2024.117436_bib5","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.tig.2008.10.012","article-title":"Co-evolution of tumor cells and their microenvironment","volume":"25","author":"Polyak","year":"2009","journal-title":"Trends Genet.: TIG"},{"issue":"15","key":"10.1016\/j.biopha.2024.117436_bib6","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/jnci\/96.15.1120","article-title":"Environmental protection: studies highlight importance of tumor microenvironment","volume":"96","author":"Hede","year":"2004","journal-title":"J. Natl. Cancer Inst."},{"issue":"45","key":"10.1016\/j.biopha.2024.117436_bib7","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1038\/onc.2008.271","article-title":"The tumor microenvironment and its role in promoting tumor growth","volume":"27","author":"Whiteside","year":"2008","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.biopha.2024.117436_bib8","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.biopha.2024.117436_bib9","doi-asserted-by":"crossref","first-page":"6655","DOI":"10.1021\/acs.nanolett.8b02340","article-title":"Immunomodulating nanomedicine for cancer therapy","volume":"18","author":"Liu","year":"2018","journal-title":"Nano Lett."},{"issue":"12","key":"10.1016\/j.biopha.2024.117436_bib10","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/nrd.2018.210","article-title":"Trial watch: The clinical trial landscape for PD1\/PDL1 immune checkpoint inhibitors","volume":"17","author":"Tang","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.biopha.2024.117436_bib11","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/nrc.2017.17","article-title":"Prospects for combining targeted and conventional cancer therapy with immunotherapy","volume":"17","author":"Gotwals","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2024.117436_bib12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.coi.2015.12.003","article-title":"Chemotherapy and immunotherapy: mapping the road ahead","volume":"39","author":"Cook","year":"2016","journal-title":"Curr. Opin. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2024.117436_bib13","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nrc.2017.121","article-title":"Targeting B cell receptor signalling in cancer: preclinical and clinical advances","volume":"18","author":"Burger","year":"2018","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.biopha.2024.117436_bib14","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3390\/cells8050449","article-title":"The B-side of Cancer Immunity: The Underrated Tune","volume":"8","author":"Largeot","year":"2019","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.biopha.2024.117436_bib15","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41577-019-0257-x","article-title":"B cells, plasma cells and antibody repertoires in the tumour microenvironment","volume":"20","author":"Sharonov","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.biopha.2024.117436_bib16","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41568-022-00466-1","article-title":"Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities","volume":"22","author":"Laumont","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2024.117436_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2017.02.008","article-title":"Yin-yang effect of tumor infiltrating B cells in breast cancer: from mechanism to immunotherapy","volume":"393","author":"Zhang","year":"2017","journal-title":"Cancer Lett."},{"issue":"8","key":"10.1016\/j.biopha.2024.117436_bib18","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/cmi.2017.35","article-title":"B cell regulation in cancer and anti-tumor immunity","volume":"14","author":"Sarvaria","year":"2017","journal-title":"Cell. Mol. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2024.117436_bib19","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1158\/2159-8290.CD-15-0827","article-title":"Bruton tyrosine kinase-dependent immune cell cross-talk drives pancreas cancer","volume":"6","author":"Gunderson","year":"2016","journal-title":"Cancer Discov."},{"issue":"9","key":"10.1016\/j.biopha.2024.117436_bib20","doi-asserted-by":"crossref","first-page":"E966","DOI":"10.1073\/pnas.1500712112","article-title":"Therapeutic antitumor immunity by checkpoint blockade is enhanced by ibrutinib, an inhibitor of both BTK and ITK","volume":"112","author":"Sagiv-Barfi","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.biopha.2024.117436_bib21","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1158\/0008-5472.CAN-11-3218","article-title":"Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma","volume":"72","author":"Erdag","year":"2012","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.biopha.2024.117436_bib22","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.4049\/jimmunol.1001323","article-title":"CD20+ B cells: the other tumor-infiltrating lymphocytes","volume":"185","author":"Nelson","year":"2010","journal-title":"J. Immunol. (Baltim., Md.: 1950)"},{"issue":"7791","key":"10.1016\/j.biopha.2024.117436_bib23","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/s41586-019-1914-8","article-title":"Tertiary lymphoid structures improve immunotherapy and survival in melanoma","volume":"577","author":"Cabrita","year":"2020","journal-title":"Nature"},{"issue":"7791","key":"10.1016\/j.biopha.2024.117436_bib24","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41586-019-1922-8","article-title":"B cells and tertiary lymphoid structures promote immunotherapy response","volume":"577","author":"Helmink","year":"2020","journal-title":"Nature"},{"issue":"7791","key":"10.1016\/j.biopha.2024.117436_bib25","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41586-019-1906-8","article-title":"B cells are associated with survival and immunotherapy response in sarcoma","volume":"577","author":"Petitprez","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biopha.2024.117436_bib26","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ccell.2020.09.004","article-title":"Immunometabolic interplay in the tumor microenvironment","volume":"39","author":"Kaymak","year":"2021","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.biopha.2024.117436_bib27","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","article-title":"Accessories to the crime: functions of cells recruited to the tumor microenvironment","volume":"21","author":"Hanahan","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biopha.2024.117436_bib28","article-title":"The role of long non-coding RNAs in the tumor immune microenvironment","volume":"13","author":"Guo","year":"2022","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.biopha.2024.117436_bib29","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ni.2703","article-title":"Innate and adaptive immune cells in the tumor microenvironment","volume":"14","author":"Gajewski","year":"2013","journal-title":"Nat. Immunol."},{"issue":"14","key":"10.1016\/j.biopha.2024.117436_bib30","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1038\/s41388-020-1190-y","article-title":"HIPK2 suppresses tumor growth and progression of hepatocellular carcinoma through promoting the degradation of HIF-1\u03b1","volume":"39","author":"Chen","year":"2020","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.biopha.2024.117436_bib31","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1038\/s41467-020-17873-3","article-title":"HIF-1\u03b1 and HIF-2\u03b1 differently regulate tumour development and inflammation of clear cell renal cell carcinoma in mice","volume":"11","author":"Hoefflin","year":"2020","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.biopha.2024.117436_bib32","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s11427-021-1999-2","article-title":"Cancer metabolism and tumor microenvironment: fostering each other?","volume":"65","author":"Yuan","year":"2022","journal-title":"Sci. China Life Sci."},{"issue":"5","key":"10.1016\/j.biopha.2024.117436_bib33","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/s41419-022-04935-1","article-title":"Cancer associated fibroblast-derived CCL5 promotes hepatocellular carcinoma metastasis through activating HIF1\u03b1\/ZEB1 axis.","volume":"13","author":"Xu","year":"2022","journal-title":"Cell death Dis."},{"issue":"5","key":"10.1016\/j.biopha.2024.117436_bib34","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/1878-0261.12046","article-title":"Gene regulatory networking reveals the molecular cue to lysophosphatidic acid-induced metabolic adaptations in ovarian cancer cells","volume":"11","author":"Ray","year":"2017","journal-title":"Mol. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2024.117436_bib35","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s13046-018-0925-x","article-title":"HIF-2\u03b1 promotes conversion to a stem cell phenotype and induces chemoresistance in breast cancer cells by activating Wnt and Notch pathways","volume":"37","author":"Yan","year":"2018","journal-title":"J. Exp. Clin. Cancer Res.: CR"},{"key":"10.1016\/j.biopha.2024.117436_bib36","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.canlet.2020.03.017","article-title":"Hypoxia in tumor microenvironment regulates exosome biogenesis: molecular mechanisms and translational opportunities","volume":"479","author":"Kumar","year":"2020","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.biopha.2024.117436_bib37","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.2353\/ajpath.2010.090786","article-title":"Elusive identities and overlapping phenotypes of proangiogenic myeloid cells in tumors","volume":"176","author":"Coffelt","year":"2010","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.biopha.2024.117436_bib38","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.devcel.2010.05.012","article-title":"Tumors as organs: complex tissues that interface with the entire organism","volume":"18","author":"Egeblad","year":"2010","journal-title":"Dev. Cell"},{"issue":"1","key":"10.1016\/j.biopha.2024.117436_bib39","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","article-title":"Macrophage diversity enhances tumor progression and metastasis","volume":"141","author":"Qian","year":"2010","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.biopha.2024.117436_bib40","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2174\/156652410791316968","article-title":"Molecular pathways linking inflammation and cancer","volume":"10","author":"Mantovani","year":"2010","journal-title":"Curr. Mol. Med."},{"issue":"4","key":"10.1016\/j.biopha.2024.117436_bib41","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrc2618","article-title":"Microenvironmental regulation of metastasis","volume":"9","author":"Joyce","year":"2009","journal-title":"Nat. Rev. Cancer"},{"issue":"7203","key":"10.1016\/j.biopha.2024.117436_bib42","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.biopha.2024.117436_bib43","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/nrc2444","article-title":"The role of myeloid cells in the promotion of tumour angiogenesis","volume":"8","author":"Murdoch","year":"2008","journal-title":"Nat. Rev. Cancer"},{"issue":"12","key":"10.1016\/j.biopha.2024.117436_bib44","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.it.2007.09.004","article-title":"Tie2-expressing monocytes: regulation of tumor angiogenesis and therapeutic implications","volume":"28","author":"De Palma","year":"2007","journal-title":"Trends Immunol."},{"key":"10.1016\/j.biopha.2024.117436_bib45","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.actbio.2021.02.026","article-title":"External cues to drive B cell function towards immunotherapy","volume":"133","author":"Stoycheva","year":"2021","journal-title":"Acta Biomater."},{"issue":"7166","key":"10.1016\/j.biopha.2024.117436_bib46","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature06287","article-title":"Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells","volume":"450","author":"Junt","year":"2007","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.biopha.2024.117436_bib47","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.4049\/jimmunol.161.3.1313","article-title":"Dendritic cells interact directly with naive B lymphocytes to transfer antigen and initiate class switching in a primary T-dependent response","volume":"161","author":"Wykes","year":"1998","journal-title":"J. Immunol. (Baltim., Md.: 1950)"},{"issue":"5780","key":"10.1016\/j.biopha.2024.117436_bib48","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1126\/science.1125703","article-title":"Extrafollicular activation of lymph node B cells by antigen-bearing dendritic cells","volume":"312","author":"Qi","year":"2006","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.biopha.2024.117436_bib49","doi-asserted-by":"crossref","first-page":"341","DOI":"10.4049\/jimmunol.140.2.341","article-title":"A novel in vivo follicular dendritic cell-dependent iccosome-mediated mechanism for delivery of antigen to antigen-processing cells","volume":"140","author":"Szakal","year":"1988","journal-title":"J. Immunol. (Baltim., Md.: 1950)"},{"issue":"24","key":"10.1016\/j.biopha.2024.117436_bib50","doi-asserted-by":"crossref","first-page":"4989","DOI":"10.1182\/blood-2009-06-229567","article-title":"B-cell follicle development remodels the conduit system and allows soluble antigen delivery to follicular dendritic cells","volume":"114","author":"Baj\u00e9noff","year":"2009","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.biopha.2024.117436_bib51","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/emboj\/19.4.513","article-title":"B cells extract and present immobilized antigen: implications for affinity discrimination","volume":"19","author":"Batista","year":"2000","journal-title":"EMBO J."},{"key":"10.1016\/j.biopha.2024.117436_bib52","first-page":"153","article-title":"Visualizing the molecular and cellular events underlying the initiation of B-cell activation","volume":"334","author":"Harwood","year":"2009","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2024.117436_bib53","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.cell.2019.10.028","article-title":"B Cells and T follicular helper cells mediate response to checkpoint inhibitors in high mutation burden mouse models of breast cancer","volume":"179","author":"Hollern","year":"2019","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.biopha.2024.117436_bib54","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/ilar.46.3.258","article-title":"Monoclonal versus polyclonal antibodies: distinguishing characteristics, applications, and information resources","volume":"46","author":"Lipman","year":"2005","journal-title":"ILAR J."},{"key":"10.1016\/j.biopha.2024.117436_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-030-79308-1_1","article-title":"Immune system in action","volume":"1342","author":"Stephen","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.biopha.2024.117436_bib56","doi-asserted-by":"crossref","unstructured":"Wennhold, K., Shimabukuro-Vornhagen, A., & von Bergwelt-Baildon, M. (2019). B Cell-Based Cancer Immunotherapy. Transfusion medicine and hemotherapy: offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie, 46(1), 36\u201346. https:\/\/doi.org\/10.1159\/000496166.","DOI":"10.1159\/000496166"},{"issue":"12","key":"10.1016\/j.biopha.2024.117436_bib57","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.trecan.2016.10.010","article-title":"B lymphocytes and cancer: a love-hate relationship","volume":"2","author":"Yuen","year":"2016","journal-title":"Trends Cancer"},{"issue":"5","key":"10.1016\/j.biopha.2024.117436_bib58","first-page":"1463","article-title":"Phenotypic analysis of tumor-infiltrating lymphocytes from human breast cancer","volume":"12","author":"Chin","year":"1992","journal-title":"Anticancer Res."},{"issue":"2","key":"10.1016\/j.biopha.2024.117436_bib59","doi-asserted-by":"crossref","first-page":"954","DOI":"10.4049\/jimmunol.172.2.954","article-title":"IL-12p70-dependent Th1 induction by human B cells requires combined activation with CD40 ligand and CpG DNA","volume":"172","author":"Wagner","year":"2004","journal-title":"J. Immunol. (Baltim., Md.: 1950)"},{"key":"10.1016\/j.biopha.2024.117436_bib60","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0065-2776(07)96002-2","article-title":"Regulation of interferon-gamma during innate and adaptive immune responses","volume":"96","author":"Schoenborn","year":"2007","journal-title":"Adv. Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2024.117436_bib61","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.67","article-title":"Interferon-\u03b3 derived from cytotoxic lymphocytes directly enhances their motility and cytotoxicity","volume":"8","author":"Bhat","year":"2017","journal-title":"Cell death Dis."},{"issue":"4","key":"10.1016\/j.biopha.2024.117436_bib62","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/nri2729","article-title":"Effector and regulatory B cells: modulators of CD4+ T cell immunity","volume":"10","author":"Lund","year":"2010","journal-title":"Nat. Rev. Immunol."},{"issue":"19","key":"10.1016\/j.biopha.2024.117436_bib63","doi-asserted-by":"crossref","first-page":"5597","DOI":"10.1158\/0008-5472.CAN-16-0431","article-title":"The emerging role of B cells in tumor immunity","volume":"76","author":"Tsou","year":"2016","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.biopha.2024.117436_bib64","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1158\/1078-0432.CCR-12-0234","article-title":"CD20+ tumor-infiltrating lymphocytes have an atypical CD27-memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancer","volume":"18","author":"Nielsen","year":"2012","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"issue":"7","key":"10.1016\/j.biopha.2024.117436_bib65","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.4049\/jimmunol.0903009","article-title":"B cells are required for optimal CD4+ and CD8+ T cell tumor immunity: therapeutic B cell depletion enhances B16 melanoma growth in mice","volume":"184","author":"DiLillo","year":"2010","journal-title":"J. Immunol. (Baltim., Md.: 1950)"},{"issue":"42","key":"10.1016\/j.biopha.2024.117436_bib66","doi-asserted-by":"crossref","first-page":"72108","DOI":"10.18632\/oncotarget.19437","article-title":"The integrative clinical impact of tumor-infiltrating T lymphocytes and NK cells in relation to B lymphocyte and plasma cell density in esophageal and gastric adenocarcinoma","volume":"8","author":"Svensson","year":"2017","journal-title":"Oncotarget"},{"issue":"16","key":"10.1016\/j.biopha.2024.117436_bib67","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.1158\/1078-0432.CCR-08-0133","article-title":"Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer","volume":"14","author":"Al-Shibli","year":"2008","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.biopha.2024.117436_bib68","article-title":"LRRC3B and its promoter hypomethylation status predicts response to anti-PD-1 based immunotherapy","volume":"14","author":"Luo","year":"2023","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2024.117436_bib69","first-page":"180","article-title":"Prognostic markers in resectable non-small cell lung cancer: a multivariate analysis","volume":"44","author":"Pelletier","year":"2001","journal-title":"Can. J. Surg. J. Can. De. Chir."},{"issue":"3A","key":"10.1016\/j.biopha.2024.117436_bib70","first-page":"1827","article-title":"Effect of IgG produced by tumor-infiltrating B lymphocytes on lung tumor growth","volume":"26","author":"Mizukami","year":"2006","journal-title":"Anticancer Res."},{"issue":"41","key":"10.1016\/j.biopha.2024.117436_bib71","doi-asserted-by":"crossref","first-page":"71002","DOI":"10.18632\/oncotarget.20238","article-title":"Tumor-infiltrating B cells producing antitumor active immunoglobulins in resected HCC prolong patient survival","volume":"8","author":"Brunner","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2024.117436_bib72","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.clim.2017.10.002","article-title":"Non-progressing cancer patients have persistent B cell responses expressing shared antibody paratopes that target public tumor antigens","volume":"187","author":"DeFalco","year":"2018","journal-title":"Clin. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2024.117436_bib73","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/jso.22093","article-title":"B lymphocytes as effector cells in the immunotherapy of cancer","volume":"105","author":"Namm","year":"2012","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.biopha.2024.117436_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.881427","article-title":"Emerging concepts regarding pro- and anti tumor properties of B cells in tumor immunity","volume":"13","author":"Qin","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2024.117436_bib75","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4049\/jimmunol.1500055","article-title":"CD11c-Expressing B Cells Are Located at the T Cell\/B Cell Border in Spleen and Are Potent APCs","volume":"195","author":"Rubtsov","year":"2015","journal-title":"J. Immunol. (Baltim., Md.: 1950)"},{"issue":"7","key":"10.1016\/j.biopha.2024.117436_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0199034","article-title":"B lymphocytes can be activated to act as antigen presenting cells to promote anti-tumor responses","volume":"13","author":"Rossetti","year":"2018","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.biopha.2024.117436_bib77","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.canlet.2013.01.036","article-title":"The prognostic relevance of tumour-infiltrating plasma cells and immunoglobulin kappa C indicates an important role of the humoral immune response in non-small cell lung cancer","volume":"333","author":"Lohr","year":"2013","journal-title":"Cancer Lett."},{"issue":"11","key":"10.1016\/j.biopha.2024.117436_bib78","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw144","article-title":"Genomic analysis of immune cell infiltrates across 11 tumor types","volume":"108","author":"Iglesia","year":"2016","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.biopha.2024.117436_bib79","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1186\/s12935-021-02004-9","article-title":"Tumor-infiltrating B cells as a favorable prognostic biomarker in breast cancer: a systematic review and meta-analysis","volume":"21","author":"Qin","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.biopha.2024.117436_bib80","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1749-6632.1997.tb52090.x","article-title":"Regulation of T and B cell responses by modulating interactions between CD28\/CTLA4 and their ligands, CD80 and CD86","volume":"815","author":"Lane","year":"1997","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.biopha.2024.117436_bib81","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1146\/annurev.immunol.23.021704.115611","article-title":"The B7 family revisited","volume":"23","author":"Greenwald","year":"2005","journal-title":"Annu. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.biopha.2024.117436_bib82","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1002\/ijc.31850","article-title":"A new perspective: exploring future therapeutic strategies for cancer by understanding the dual role of B lymphocytes in tumor immunity","volume":"144","author":"Liu","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.biopha.2024.117436_bib83","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ctrv.2018.12.001","article-title":"B cell and B cell-related pathways for novel cancer treatments","volume":"73","author":"Tokunaga","year":"2019","journal-title":"Cancer Treat. Rev."},{"issue":"5","key":"10.1016\/j.biopha.2024.117436_bib84","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s11596-019-2092-5","article-title":"Double-edge Role of B Cells in Tumor Immunity: Potential Molecular Mechanism","volume":"39","author":"Zhao","year":"2019","journal-title":"Curr. Med. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2024.117436_bib85","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1074-7613(02)00274-1","article-title":"Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation","volume":"16","author":"Mizoguchi","year":"2002","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.biopha.2024.117436_bib86","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/hep.32442","article-title":"Ten-eleven translocation-2 inactivation restrains IL-10-producing regulatory B cells to enable antitumor immunity in hepatocellular carcinoma","volume":"77","author":"Lu","year":"2023","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.biopha.2024.117436_bib87","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.immuni.2022.11.014","article-title":"Immune checkpoint therapy-elicited sialylation of IgG antibodies impairs antitumorigenic type I interferon responses in hepatocellular carcinoma","volume":"56","author":"Wu","year":"2023","journal-title":"Immunity"},{"issue":"7885","key":"10.1016\/j.biopha.2024.117436_bib88","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41586-021-04082-1","article-title":"B cell-derived GABA elicits IL-10+ macrophages to limit anti-tumour immunity","volume":"599","author":"Zhang","year":"2021","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.biopha.2024.117436_bib89","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.immuni.2015.04.005","article-title":"Regulatory B cells: origin, phenotype, and function","volume":"42","author":"Rosser","year":"2015","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.biopha.2024.117436_bib90","doi-asserted-by":"crossref","first-page":"6581","DOI":"10.1007\/s13277-015-4538-0","article-title":"Regulatory B cells contribute to the impaired antitumor immunity in ovarian cancer patients","volume":"37","author":"Wei","year":"2016","journal-title":"Tumour Biol.: J. Int. Soc. Oncodev. Biol. Med."},{"issue":"7","key":"10.1016\/j.biopha.2024.117436_bib91","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1158\/0008-5472.CAN-12-4184","article-title":"Anti-CD20 antibody promotes cancer escape via enrichment of tumor-evoked regulatory B cells expressing low levels of CD20 and CD137L","volume":"73","author":"Bodogai","year":"2013","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.biopha.2024.117436_bib92","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/modpathol.2016.28","article-title":"Plasma cells in primary melanoma. Prognostic significance and possible role of IgA","volume":"29","author":"Bosisio","year":"2016","journal-title":"Mod. Pathol.: Off. J. U. S. Can. Acad. Pathol., Inc."},{"issue":"7680","key":"10.1016\/j.biopha.2024.117436_bib93","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nature24302","article-title":"Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity","volume":"551","author":"Shalapour","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biopha.2024.117436_bib94","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/imr.12939","article-title":"Regulatory B cells in cancer","volume":"299","author":"Michaud","year":"2021","journal-title":"Immunol. Rev."},{"issue":"7550","key":"10.1016\/j.biopha.2024.117436_bib95","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature14395","article-title":"Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy","volume":"521","author":"Shalapour","year":"2015","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.biopha.2024.117436_bib96","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1158\/2159-8290.CD-15-0843","article-title":"IL35-producing B cells promote the development of pancreatic neoplasia","volume":"6","author":"Pylayeva-Gupta","year":"2016","journal-title":"Cancer Discov."},{"issue":"3","key":"10.1016\/j.biopha.2024.117436_bib97","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1158\/2326-6066.CIR-19-0349","article-title":"B cell-Derived IL35 Drives STAT3-Dependent CD8+ T-cell exclusion in pancreatic cancer.","volume":"8","author":"Mirlekar","year":"2020","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.biopha.2024.117436_bib98","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.molimm.2020.01.008","article-title":"PD-L1+ regulatory B cells act as a T cell suppressor in a PD-L1-dependent manner in melanoma patients with bone metastasis","volume":"119","author":"Wu","year":"2020","journal-title":"Mol. Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2024.117436_bib99","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1158\/2159-8290.CD-15-1408","article-title":"PD-1hi Identifies a Novel Regulatory B-cell population in human hepatoma that promotes disease progression","volume":"6","author":"Xiao","year":"2016","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.biopha.2024.117436_bib100","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1880687","article-title":"IgG4 induces tolerogenic M2-like macrophages and correlates with disease progression in colon cancer","volume":"10","author":"Jordakieva","year":"2021","journal-title":"Oncoimmunology"},{"issue":"2","key":"10.1016\/j.biopha.2024.117436_bib101","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000661","article-title":"An immune evasion mechanism with IgG4 playing an essential role in cancer and implication for immunotherapy","volume":"8","author":"Wang","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"10","key":"10.1016\/j.biopha.2024.117436_bib102","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1158\/0008-5472.CAN-10-4316","article-title":"Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4\u207a T cells to T-regulatory cells","volume":"71","author":"Olkhanud","year":"2011","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.biopha.2024.117436_bib103","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1873585","article-title":"Inflammatory B cells correlate with failure to checkpoint blockade in melanoma patients","volume":"10","author":"de Jonge","year":"2021","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.biopha.2024.117436_bib104","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200851","article-title":"B cells and cancer: to B or not to B?","volume":"218","author":"Fridman","year":"2021","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.biopha.2024.117436_bib105","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11523-017-0538-x","article-title":"The role of B-cell maturation antigen in the biology and management of, and as a potential therapeutic target in, multiple myeloma","volume":"13","author":"Sanchez","year":"2018","journal-title":"Target. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2024.117436_bib106","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jtho.2020.09.027","article-title":"Neoadjuvant Chemotherapy Increases Cytotoxic T Cell, Tissue Resident Memory T Cell, and B Cell Infiltration in Resectable NSCLC","volume":"16","author":"Gaudreau","year":"2021","journal-title":"J. Thorac. Oncol.: Off. Publ. Int. Assoc. Study Lung Cancer"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224013222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224013222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:21:08Z","timestamp":1784762468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224013222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":106,"alternative-id":["S0753332224013222"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117436","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor-infiltrating B cells: Their dual mechanistic roles in the tumor microenvironment","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117436","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117436"}}